Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and Without Underlying Immunosuppressive Conditions
<b>Background</b>: Pandemic influenza may cause substantial morbidity and mortality, especially in older adults and those with immunosuppressive conditions. <b>Methods</b>: In this phase 3, stratified, randomized, controlled, observer-blind, multicenter trial, we evaluated th...
Saved in:
| Main Authors: | Peter Malfertheiner, Eve Versage, Esther Van Twuijver, Giuliano Rizzardini, Matthew Hohenboken |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/4/379 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and immunogenicity profiles of an adjuvanted seasonal influenza vaccine in Guatemalan children
by: Adib Rodriguez Solares, et al.
Published: (2014-09-01) -
Similar humoral responses but distinct CD4+ T cell transcriptomic profiles in older adults elicited by MF59 adjuvanted and high dose influenza vaccines
by: Huy Quang Quach, et al.
Published: (2024-10-01) -
A novel adjuvant system BK-02 with CpG2006 and MF59 enhances the immunogenicity of a herpes zoster subunit vaccine
by: Zihan Wang, et al.
Published: (2025-07-01) -
Historic Influenza Perspectives on an Influenza Pandemic
by: Des Martins
Published: (2003-04-01) -
Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccines
by: Allegra Peletta, et al.
Published: (2024-07-01)